During the past decade, INQUIS Clinical Research conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "INQUIS Clinical Research" #1 sponsor was "PepsiCo Global R&D" with 3 trials, followed by "NuBiyota" with 2 trials sponsored, "Nutricia Research" with 2 trials sponsored, "Anderson Advanced Ingredients" with 1 trials sponsored and "Cambridge Glycoscience" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "INQUIS Clinical Research" #1 collaborator was "INQUIS Clinical Research Ltd." with 5 trials as a collaborator, "Glycemic Index Laboratories, Inc" with 2 trials as a collaborator, "Cereal Partners Worldwide" with 1 trials as a collaborator, "DSM Nutritional Products, Inc." with 1 trials as a collaborator and "Glycemia Consulting Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "INQUIS Clinical Research" are "Glycemic Response" (3 trials), "Alcohol Use, Unspecified" (1 trials), "Blood Sugar" (1 trials), "Diabetes Mellitus" (1 trials) and "Dysglycemia" (1 trials). Many other conditions were trialed in "INQUIS Clinical Research" in a lesser frequency.

Most popular intervention types in "INQUIS Clinical Research" are "Other" (8 trials), "Dietary Supplement" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "140 calories per 30 gram test meal" (1 trials), "ALLSWEET®" (1 trials), "ALLSWEET® and sucrose" (1 trials), "Ca-propionate 1 g" (1 trials) and "Ca-propionate 3 g" (1 trials). Other intervention names were less common.

The vast majority of trials in "INQUIS Clinical Research" are 14 trials for "All" genders.

Currently, there are NaN active trials in "INQUIS Clinical Research". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in INQUIS Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in INQUIS Clinical Research, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".